1997
DOI: 10.1023/a:1005791623733
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Dystonia is a rare neurologic disorder of the basal ganglia presenting with involuntary twisting or turning spasm of muscles. Movements localized to the face, eyes, or neck generally present during late adulthood. Cranial dystonia is usually idiopathic but may be caused by trauma or medications. Of 148 patients with focal dystonia referred to Indiana University over four years, four women had the onset of face and neck symptoms eight days to 34 months after completing treatment with chemotherapy alone or combi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2003
2003
2019
2019

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…To the best of our knowledge oromandibular dystonia is never reported after the administration of other forms of 5-FU. Focal dystonia, however, caused by 5-FU has been reported in one earlier case series including three cases [ 6 ]. Due to the serious nature of this adverse event, although rare, we are convinced that physicians should be aware of this.…”
Section: Discussionmentioning
confidence: 99%
“…To the best of our knowledge oromandibular dystonia is never reported after the administration of other forms of 5-FU. Focal dystonia, however, caused by 5-FU has been reported in one earlier case series including three cases [ 6 ]. Due to the serious nature of this adverse event, although rare, we are convinced that physicians should be aware of this.…”
Section: Discussionmentioning
confidence: 99%
“…In the CYP2D6 –metoclopramide case report, the chemotherapy that the patients received could have been equally culpable of the dystonic reactions. Chemotherapeutic agents have been reported to cause dystonia, possibly by adversely affecting the movement-related brain circuits, i.e., those housed in the basal ganglia (Brashear and Siemers, 1997).…”
Section: Introductionmentioning
confidence: 99%